Hi Attitudes, All Shareholders have Time as their 'qualification' and especially those invested for a considerable amount of time. As you are well aware, I can easily list many, many links to references via the OBJ website, ASX Announcements, Clinical Trials & previous Hotcopper posts from a well-balanced spectrum of posters. How much 'time' does it actually take to add OBJ's Tech to products? More than 10 years for non-pharmaceutical? Or was that originally pitched to Shareholders as 10 years for a pharmaceutical application? 'Time' is proving that the pharmaceutical route would have been quicker.
I do very much agree with Mak on one of his points...another 6-12 will make all the difference either way. In the meantime, I don't see it as whining; rather just discussing and planning out future scenarios as they evolve based on the facts - rather than burying heads in the sand until a particular reality is already upon us.
Shareholders probably wouldn't spend so much time on Hotcopper discussing possible OBJ scenarios if OBJ Management would only engage more adept communication protocols with the Market in general. That's a suggestion, not a whine.
It's interesting Mak that you equate BOD discussion as whining but seem content with BOD communication and all product progress. The reason why Shareholders 'rehash' past BOD behaviour is that we need to remind ourselves that we don't want a repeat of them in the future. Companies must be held accountable and this BOD has had a dream run of uninterrupted power since inception 13 years ago. Nov 2017. Tick. Tock.
OBJ Price at posting:
6.4¢ Sentiment: Buy Disclosure: Held
(20min delay)